Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Drug Manufacturers — Specialty and Generic

Ironwood Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of cholesterol, gastrointestinal, and cardiovascular diseases, as well as pain, inflammation, and others.
Website: ironwoodpharma.com


  • Good financial results growth rate 107.0% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-2.8%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 10.5% (LTM)
  • Share price is 654.0% higher than minimum and 72.4% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (5.9x vs 6.8x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: IRWD
Share price, USD:  (0.0%)4.27
year average price 1.70  


year start price 4.58 2025-01-09

max close price 4.58 2025-01-09

min close price 0.57 2025-05-23

current price 4.27 2026-01-08
Common stocks: 153 837 992

Dividend Yield:  0.0%
FCF Yield LTM: 10.5%
EV / LTM EBITDA: 5.9x
EV / EBITDA annualized: 3.7x
Last revenue growth (y/y):  +32.6%
Last growth of EBITDA (y/y):  +181.5%
Historical revenue growth:  -6.8%
Historical growth of EBITDA:  +1.2%
EV / Sales: 3.3x
Margin (EBITDA LTM / Revenue): 55.5%

Target EV / EBITDA (hist percentile): 6.8x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 657
Net Debt ($m): 458
EV (Enterprise Value): 1 115
EBITDA LTM (млн $): 188
EV / LTM EBITDA: 5.9x
Price to Book: -2.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-02businesswire.com

Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance

2025-11-27zacks.com

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?

2025-11-21zacks.com

Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?

2025-11-13zacks.com

IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?

2025-11-10businesswire.com

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

2025-10-14zacks.com

Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term

2025-08-08zacks.com

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

2025-08-07businesswire.com

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

2025-05-08zacks.com

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

2025-04-25businesswire.com

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-07 2024-08-08 2024-05-09 2024-02-16 2023-11-09 2023-08-09 2023-05-04 2023-02-16 2022-11-03
acceptedDate 2025-11-10 07:01:07 2025-08-11 16:13:45 2024-11-07 17:22:17 2024-08-08 16:06:09 2024-05-09 16:46:11 2024-02-16 07:01:34 2023-11-09 16:18:17 2023-08-09 16:02:57 2023-05-04 16:05:54 2023-02-16 17:21:07 2022-11-03 16:06:19
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 122M 85M 92M 94M 75M 118M 114M 107M 104M 107M 109M
costOfRevenue 0 0 0 506 000 513 000 512 000 507 000 0 0 0 0
grossProfit 122M 85M 92M 94M 74M 117M 113M 107M 104M 107M 109M
grossProfitRatio 1 1 1 0.995 0.993 0.996 0.996 1 1 1 1
researchAndDevelopmentExpenses 22M 23M 30M 30M 25M 35M 33M 1 125M 13M 10M 12M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 22M 17M 36M 37M 38M 38M 36M 52M 31M 28M 29M
otherExpenses 2M -250 000 16 000 0 0 6M 0 0 0 0 0
operatingExpenses 47M 40M 66M 67M 63M 73M 69M 1 178M 44M 39M 40M
costAndExpenses 47M 40M 66M 67M 63M 73M 69M 1 178M 44M 39M 40M
interestIncome 930 000 818 000 1M 1M 1M 1M 2M 9M 7M 5M 3M
interestExpense 8M 8M 9M 7M 7M 8M 10M 2M 2M 2M 1M
depreciationAndAmortization 475 000 467 000 507 000 506 000 513 000 512 000 507 000 22M 7M 5M 3M
ebitda 77M 47M 27M 27M 12M 45M 46M -1 061M 67M 74M 71M
ebitdaratio 0.63 0.547 0.298 0.292 0.16 0.382 0.408 -9.884 0.647 0.689 0.656
operatingIncome 75M 45M 26M 27M 11M 44M 40M -1 083M 60M 68M 68M
operatingIncomeRatio 0.618 0.532 0.28 0.286 0.153 0.378 0.352 -10.087 0.578 0.638 0.63
totalOtherIncomeExpensesNet -7M -7M -8M -8M -6M -14M -5M -13M 6M 4M 1M
incomeBeforeTax 68M 38M 17M 19M 5M 30M 32M -1 076M 66M 72M 70M
incomeBeforeTaxRatio 0.557 0.444 0.19 0.2 0.066 0.258 0.281 -10.022 0.633 0.674 0.643
incomeTaxExpense 28M 14M 14M 20M 9M 32M 18M 13M 20M 23M 20M
netIncome 40M 24M 31M -860 000 -4M -1M 15M -1 062M 46M 49M 50M
netIncomeRatio 0.328 0.277 0.339 -0.009 -0.056 -0.009 0.135 -9.892 0.439 0.456 0.463
eps 0.25 0.15 0.19 -0.005 -0.026 -0.007 0.098 -6.84 0.3 0.32 0.33
epsdiluted 0.23 0.14 0.19 -0.005 -0.026 -0.007 0.082 -6.84 0.25 0.27 0.28
weightedAverageShsOut 162M 162M 160M 159M 158M 156M 156M 155M 154M 153M 153M
weightedAverageShsOutDil 178M 162M 160M 159M 158M 156M 187M 155M 187M 185M 184M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-07 2024-08-08 2024-05-09 2024-02-16 2023-11-09 2023-08-09 2023-05-04 2023-02-16 2022-11-03
acceptedDate 2025-11-10 07:01:07 2025-08-11 16:13:45 2024-11-07 17:22:17 2024-08-08 16:06:09 2024-05-09 16:46:11 2024-02-16 07:01:34 2023-11-09 16:18:17 2023-08-09 16:02:57 2023-05-04 16:05:54 2023-02-16 17:21:07 2022-11-03 16:06:19
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 140M 93M 88M 106M 122M 92M 110M 175M 740M 656M 574M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 140M 93M 88M 106M 122M 92M 110M 175M 740M 656M 574M
netReceivables 120M 86M 76M 58M 72M 129M 125M 119M 116M 115M 117M
inventory 0 0 0 0 0 1 788 000 788 000 1M 1M 0
otherCurrentAssets 13M 13M 14M 15M 15M 12M 18M 23M 9M 8M 8M
totalCurrentAssets 274M 192M 179M 178M 208M 233M 254M 318M 866M 781M 699M
propertyPlantEquipmentNet 13M 14M 16M 17M 17M 18M 19M 19M 20M 20M 21M
goodwill 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 2M 2M 3M 3M 3M 4M 4M 4M 0 0 0
goodwillAndIntangibleAssets 2M 2M 3M 3M 3M 4M 4M 4M 0 0 0
longTermInvestments 0 0 0 0 0 -1 510 000 0 0 0 0
taxAssets 102M 129M 185M 193M 206M 212M 244M 258M 268M 284M 305M
otherNonCurrentAssets 5M 5M 6M 4M 3M 4M 4M 4M 1M 16M 16M
totalNonCurrentAssets 122M 151M 211M 217M 231M 238M 270M 286M 289M 320M 341M
otherAssets 0 0 0 0 0 1 0 0 0 0 0
totalAssets 396M 343M 390M 396M 439M 471M 524M 603M 1 155M 1 101M 1 040M
accountPayables 2M 1M 3M 3M 6M 8M 5M 4M 118 000 483 000 795 000
shortTermDebt 203M 203M 3M 6M 203M 203M 202M 202M 3M 3M 3M
taxPayables 0 764 000 986 000 935 000 2M 1M 1M 7M 0 0 0
deferredRevenue 1M 978 000 0 935 000 2M 1M 59M 0 0 0 0
otherCurrentLiabilities 37M 27M 42M 35M 41M 64M 14M 100M 21M 22M 23M
totalCurrentLiabilities 243M 233M 49M 46M 252M 276M 281M 305M 24M 26M 27M
longTermDebt 395M 396M 225M 637M 473M 498M 538M 614M 413M 413M 413M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 22M 22M 427M 35M 43M 43M 31M 31M 12M 10M 418M
totalNonCurrentLiabilities 418M 419M 651M 672M 517M 541M 569M 645M 425M 423M 422M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 14M 14M 16M 17M 14M 15M 18M 19M 19M 20M 20M
totalLiabilities 660M 651M 701M 717M 769M 817M 850M 950M 448M 448M 449M
preferredStock 0 0 0 0 0 0 0 0 0 0 0
commonStock 163 000 162 000 160 000 160 000 159 000 156 000 156 000 156 000 155 000 154 000 153 000
retainedEarnings -1 671M -1 712M -1 700M -1 704M -1 703M -1 699M -1 698M -1 713M -651M -696M -745M
accumulatedOtherComprehensiveIncomeLoss -2M -2M -2M -470 000 -922 000 -3M -752 000 0 0 0 0
othertotalStockholdersEquity 1 409M 1 405M 1 391M 1 382M 1 373M 1 355M 1 372M 1 366M 1 357M 1 349M 1 336M
totalStockholdersEquity -264M -308M -311M -322M -331M -346M -326M -347M 707M 652M 591M
totalEquity -264M -308M -311M -322M -331M -346M -328M -348M 707M 652M 591M
totalLiabilitiesAndStockholdersEquity 396M 343M 390M 396M 439M 471M 524M 603M 1 155M 1 101M 1 040M
minorityInterest 0 0 0 0 0 0 -2M -1M 0 0 0
totalLiabilitiesAndTotalEquity 396M 343M 390M 396M 439M 471M 524M 603M 1 155M 1 101M 1 040M
totalInvestments 0 0 0 0 0 -1 510 000 0 0 0 0
totalDebt 598M 599M 215M 640M 690M 716M 741M 816M 416M 416M 416M
netDebt 458M 506M 127M 535M 569M 623M 630M 640M -325M -240M -158M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD IRWD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-11 2024-11-07 2024-08-08 2024-05-09 2024-02-16 2023-11-09 2023-08-09 2023-05-04 2023-02-16 2022-11-03
acceptedDate 2025-11-10 07:01:07 2025-08-11 16:13:45 2024-11-07 17:22:17 2024-08-08 16:06:09 2024-05-09 16:46:11 2024-02-16 07:01:34 2023-11-09 16:18:17 2023-08-09 16:02:57 2023-05-04 16:05:54 2023-02-16 17:21:07 2022-11-03 16:06:19
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 40M 24M 4M -860 000 -4M -1M 14M -1 089M 46M 49M 50M
depreciationAndAmortization 475 000 467 000 507 000 506 000 513 000 512 000 507 000 270 000 286 000 340 000 363 000
deferredIncomeTax 28M 14M 8M 13M 6M 31M 14M 10M 17M 20M 16M
stockBasedCompensation 4M 5M 8M 9M 8M 9M 8M 8M 7M 7M 7M
changeInWorkingCapital -25M -59M -11M 11M 34M -9M -5M 15M 10M 2M -5M
accountsReceivables -34M -46M 0 14M 57M -5M -6M -3M 14M 937 000 -14M
inventory 0 0 0 0 0 0 0 0 0 0 0
accountsPayables 11M -14M 0 -2M -13M -13M 7M 18M 705 000 -2M 5M
otherWorkingCapital -2M 2M -11M -502 000 -11M 9M -6M 578 000 -15M 3M 5M
otherNonCashItems 851 000 919 000 355 000 -2M -35M 5M 586 000 1 091M 383 000 420 000 249 000
netCashProvidedByOperatingActivities 48M -15M 10M 33M 45M 36M 32M 35M 80M 79M 69M
investmentsInPropertyPlantAndEquipment -2000 -2000 0 -58 000 -68 000 -211 000 -49 000 0 -13 000 27 000 -66 000
acquisitionsNet 0 0 0 0 0 -4M -23M 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -16 000 -58 000 0 1 -23M -999M 0 0 0
netCashUsedForInvestingActivites -2000 -2000 -16 000 -58 000 -68 000 -4M -23M -999M -13 000 27 000 -66 000
debtRepayment 0 0 -25M -50M -25M -23M -75M 0 0 0 0
commonStockIssued 0 88 000 0 0 10M 998 000 12 000 0 4M 10M 0
commonStockRepurchased 0 0 0 0 -616 000 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 -2M -121 000 -616 000 -29M -75M 399M 0 -7M 797 000
netCashUsedProvidedByFinancingActivities 0 88 000 -27M -49M -16M -51M -75M 399M 4M 3M 797 000
effectOfForexChangesOnCash -26 000 -647 000 -26 000 -51 000 24 000 -50 000 -3000 -35M 0 0 0
netChangeInCash 48M -16M -17M -16M 29M -19M -65M -565M 84M 82M 70M
cashAtEndOfPeriod 140M 93M 88M 106M 122M 92M 111M 177M 742M 658M 576M
cashAtBeginningOfPeriod 93M 108M 106M 122M 92M 111M 177M 742M 658M 576M 506M
operatingCashFlow 48M -15M 10M 33M 45M 36M 32M 35M 80M 79M 69M
capitalExpenditure -2000 -2000 0 -58 000 -68 000 -211 000 -49 000 0 -13 000 27 000 -66 000
freeCashFlow 48M -15M 10M 33M 45M 36M 32M 35M 80M 79M 69M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-11-07 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-09 ET (fiscal 2024 q1)
2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-11-09 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-10 07:12 ET
Ironwood Pharmaceuticals published news for 2025 q3
SEC form 8
2025-11-10 07:12 ET
Ironwood Pharmaceuticals published news for 2025 q3
SEC form 10
2025-11-10 07:01 ET
Ironwood Pharmaceuticals reported for 2025 q3
SEC form 10
2025-08-11 20:13 ET
Ironwood Pharmaceuticals published news for 2025 q2
SEC form 8
2025-08-07 11:11 ET
Ironwood Pharmaceuticals published news for 2025 q2
SEC form 8
2025-08-07 11:11 ET
Ironwood Pharmaceuticals reported for 2025 q2
SEC form 8
2025-07-10 20:06 ET
Ironwood Pharmaceuticals published news for 2025 q2
SEC form 8
2025-07-10 20:06 ET
Ironwood Pharmaceuticals published news for 2025 q2
SEC form 10
2025-05-12 20:36 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 10
2025-05-12 00:00 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 8
2025-05-07 11:11 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 8
2025-05-07 11:11 ET
Ironwood Pharmaceuticals reported for 2025 q1
SEC form 8
2025-04-25 00:00 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 8
2025-04-25 00:00 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 8
2025-04-14 11:07 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 8
2025-04-14 11:07 ET
Ironwood Pharmaceuticals published news for 2025 q1
SEC form 10
2025-03-31 11:07 ET
Ironwood Pharmaceuticals published news for 2024 q4
SEC form 10
2025-03-31 00:00 ET
Ironwood Pharmaceuticals published news for 2024 q4
SEC form 8
2025-02-27 07:08 ET
Ironwood Pharmaceuticals published news for 2024 q4
SEC form 8
2025-02-27 07:08 ET
Ironwood Pharmaceuticals reported for 2024 q4
SEC form 10
2024-11-07 17:22 ET
Ironwood Pharmaceuticals reported for 2024 q3
SEC form 8
2024-11-07 07:07 ET
Ironwood Pharmaceuticals published news for 2024 q3
SEC form 8
2024-11-07 07:07 ET
Ironwood Pharmaceuticals published news for 2024 q3
SEC form 10
2024-08-08 16:06 ET
Ironwood Pharmaceuticals published news for 2024 q2
SEC form 8
2024-08-08 07:07 ET
Ironwood Pharmaceuticals published news for 2024 q2
SEC form 8
2024-08-08 07:07 ET
Ironwood Pharmaceuticals reported for 2024 q2
SEC form 10
2024-08-08 00:00 ET
Ironwood Pharmaceuticals published news for 2024 q2
SEC form 10
2024-05-09 00:00 ET
Ironwood Pharmaceuticals reported for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Ironwood Pharmaceuticals published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Ironwood Pharmaceuticals published news for 2024 q1
SEC form 10
2024-02-16 00:00 ET
Ironwood Pharmaceuticals reported for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q4
SEC form 10
2023-11-09 16:18 ET
Ironwood Pharmaceuticals published news for 2023 q3
SEC form 8
2023-11-09 07:07 ET
Ironwood Pharmaceuticals reported for 2023 q3
SEC form 10
2023-11-09 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q3
SEC form 10
2023-08-09 16:02 ET
Ironwood Pharmaceuticals published news for 2023 q2
SEC form 10
2023-08-09 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q2
SEC form 6
2023-08-08 07:08 ET
Ironwood Pharmaceuticals reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q2
SEC form 6
2023-06-30 16:05 ET
Ironwood Pharmaceuticals published news for 2023 q1
SEC form 6
2023-06-22 16:08 ET
Ironwood Pharmaceuticals published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Ironwood Pharmaceuticals published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Ironwood Pharmaceuticals reported for 2023 q1
SEC form 6
2023-04-11 08:30 ET
Ironwood Pharmaceuticals published news for 2023 q1
SEC form 10
2023-02-16 17:21 ET
Ironwood Pharmaceuticals reported for 2022 q4
SEC form 6
2023-02-16 07:09 ET
Ironwood Pharmaceuticals published news for 2022 q4
SEC form 10
2023-02-16 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q4
SEC form 8
2023-02-16 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q4
SEC form 6
2023-01-09 06:30 ET
Ironwood Pharmaceuticals published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Ironwood Pharmaceuticals published news for 2022 q4
SEC form 6
2022-12-19 16:14 ET
Ironwood Pharmaceuticals published news for 2022 q3
SEC form 10
2022-11-03 16:06 ET
Ironwood Pharmaceuticals reported for 2022 q3
SEC form 6
2022-11-03 07:00 ET
Ironwood Pharmaceuticals published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q3
SEC form 10
2022-08-04 16:11 ET
Ironwood Pharmaceuticals reported for 2022 q2
SEC form 6
2022-08-04 07:06 ET
Ironwood Pharmaceuticals published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q2
SEC form 6
2022-06-08 16:05 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 6
2022-06-03 16:06 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 6
2022-06-03 16:06 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 6
2022-06-03 16:06 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 6
2022-06-03 16:05 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 6
2022-06-03 16:05 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 10
2022-05-05 16:07 ET
Ironwood Pharmaceuticals reported for 2022 q1
SEC form 6
2022-05-05 07:07 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Ironwood Pharmaceuticals reported for 2022 q1
SEC form 6
2022-04-21 16:12 ET
Ironwood Pharmaceuticals published news for 2022 q1
SEC form 10
2022-02-18 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 10
2022-02-17 17:46 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 6
2022-02-17 07:06 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 8
2022-02-17 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 6
2022-01-10 07:33 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q4
SEC form 6
2021-12-01 07:37 ET
Ironwood Pharmaceuticals published news for 2021 q3
SEC form 10
2021-11-04 16:07 ET
Ironwood Pharmaceuticals published news for 2021 q3
SEC form 6
2021-11-04 07:19 ET
Ironwood Pharmaceuticals published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q3
SEC form 10
2021-08-05 16:08 ET
Ironwood Pharmaceuticals published news for 2021 q2
SEC form 6
2021-08-05 07:05 ET
Ironwood Pharmaceuticals published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q2
SEC form 6
2021-07-22 16:07 ET
Ironwood Pharmaceuticals published news for 2021 q2
SEC form 6
2021-06-24 17:16 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 6
2021-06-07 16:06 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 6
2021-06-03 17:10 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 10
2021-05-06 16:10 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 6
2021-05-06 07:07 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 6
2021-04-22 16:12 ET
Ironwood Pharmaceuticals published news for 2021 q1
SEC form 6
2021-03-30 16:43 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 6
2021-03-15 16:53 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 10
2021-02-17 16:12 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 6
2021-02-17 07:07 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 6
2021-02-08 16:09 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 6
2021-01-11 07:34 ET
Ironwood Pharmaceuticals published news for 2020 q4
SEC form 6
2020-12-16 16:00 ET
Ironwood Pharmaceuticals published news for 2020 q3
SEC form 6
2020-12-03 08:36 ET
Ironwood Pharmaceuticals published news for 2020 q3
SEC form 10
2020-11-05 16:49 ET
Ironwood Pharmaceuticals published news for 2020 q3
SEC form 6
2020-11-05 16:11 ET
Ironwood Pharmaceuticals published news for 2020 q3